Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease. (7th November 2013)

Record Type:
Journal Article
Title:
Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease. (7th November 2013)
Main Title:
Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease
Authors:
Hughes, Tasha
Iodice, Gail
Basu, Sanjib
Bines, Steven
Kaufman, Howard
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 1(2013)Supplement 1
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Issue Display:
Volume 1, Issue 1 (2013)
Year:
2013
Volume:
1
Issue:
1
Issue Sort Value:
2013-0001-0001-0000
Page Start:
Page End:
Publication Date:
2013-11-07
Subjects:
Melanoma -- Renal Cell Carcinoma -- Median Survival -- Stable Disease -- Progressive Disease
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/2051-1426-1-S1-P105 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19215.xml